Holland shoulder replacement device firm gets $21.6M financing

HOLLAND–Shoulder Innovations LLC, a developer of shoulder replacement systems, announced that it has closed an oversubscribed $21.6 million equity financing.

US The fundraising, led by Menlo Park, Calif.-based private equity firms US Venture Partners and Lightstone Ventures, also included participation by Boston-bsaed Alumni Venture Partners, Grand Rapids-based Wakestream Ventures LLC, the Biosciences Research and Commercialization Center of Western Michigan University, Invest Michigan, and the Michigan Angel Fund, among others.

Founded in 2009 by Stephen B. Gunther, M.D., and Mike DeVries of EDF Ventures, Shoulder Innovations set out to develop a shoulder socket (glenoid) system for shoulder replacement. For the five years that followed, Shoulder Innovations successfully secured meaningful issued patents, clearance for the novel technology, and provided evidence to the surgical community through publication of multiple peer-reviewed publications. In 2015, Genesis Innovation Group partnered with Shoulder Innovations to provide financial capital and operational leadership focused on commercializing the technology. The following year, Shoulder Innovations was able to report its first commercial sale of the InSet glenoid. Continued investment led by Genesis and its cultivate(MD) Capital Funds, together with leadership from industry veterans, drove continued growth and innovation at the company.

Publication of almost 10 year clinical outcomes of SI’s innovative InSet glenoid product served to increase interest and commercial acceleration of the product. “When I first conceived of the InSet glenoid years ago, I knew it would solve the problem of glenoid loosening. We now have the science and the commercial success to back it up,” said Stephen B. Gunther M.D., founder and inventor of the InSet technology.

With five FDA 510k clearances granted and several additional products presently going through the FDA clearance process, the funds will primarily be allocated to product development and broadening commercialization of a full platform of shoulder replacement products.

“What’s exciting about the shoulder replacement market is that we are still solving surgical challenges that result in tangible improvements in patient lives,” said Don Running, who leads the company’s research and development. “The innovations we’ve produced at SI represent a step function improvement in both surgical technique and product design. We’re looking forward to seeing these improvements and the resulting positive impact on patient lives.”

Added company CEO Kevin Sidow: “Shoulder Innovations, together with our surgeon partners, have been hard at work building a highly innovative, world class product line for shoulder replacement built on unmatched innovation and sound clinical thinking. This financing comes at the perfect time to deploy our new products in an exciting market, driven by a high performance team of experienced professionals. I couldn’t be more excited about where we can take this,” said Rob Ball, Chief Executive Officer of Shoulder Innovations.

With the close of the equity financing, the Board of Directors has been expanded to six members, including two independent board members. Casey Tansey of USVP and Mike Carusi of Lightstone Ventures will join the board representing Series C shareholders. Rob Ball and Matt Ahearn will remain on the board representing Series A and B shareholders. Additionally, Kevin Sidow and Paul Buckman will join as independent directors, rounding out a highly experienced and broad knowledge base.

More at shoulderinnovations.com.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.